Chile vs Togo: The number of people with susceptibility test result for rifampicin
Chile
1,772
in 2021
Togo
1,805
in 2021
Chile rank
53rd
Togo rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Chile
- Togo
How they compare
Togo currently reports 1,805 against 1,772 in Chile, a difference of 33.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Chile ahead.
Chile ranks 53rd and Togo ranks 52nd of 155 countries.
Across the 2 decades both report, Chile averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Chile | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,721 | 732 | 988.67 | Chile |
| 2020s | 1,641 | 1,709 | 68 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chile or Togo?
- Togo, at 1,805 against 1,772 in Chile as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chile and Togo?
- 33, with Togo ahead.
- How many years of comparable data are there for Chile and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Chile and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Chile ranks 53rd and Togo ranks 52nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.